These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33675144)

  • 1. Subthalamic beta band suppression reflects effective neuromodulation in chronic recordings.
    Feldmann LK; Neumann WJ; Krause P; Lofredi R; Schneider GH; Kühn AA
    Eur J Neurol; 2021 Jul; 28(7):2372-2377. PubMed ID: 33675144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.
    Trager MH; Koop MM; Velisar A; Blumenfeld Z; Nikolau JS; Quinn EJ; Martin T; Bronte-Stewart H
    Neurobiol Dis; 2016 Dec; 96():22-30. PubMed ID: 27553876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic beta dynamics mirror Parkinsonian bradykinesia months after neurostimulator implantation.
    Steiner LA; Neumann WJ; Staub-Bartelt F; Herz DM; Tan H; Pogosyan A; Kuhn AA; Brown P
    Mov Disord; 2017 Aug; 32(8):1183-1190. PubMed ID: 28639263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
    Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
    Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic span of beta oscillations predicts deep brain stimulation efficacy for patients with Parkinson's disease.
    Zaidel A; Spivak A; Grieb B; Bergman H; Israel Z
    Brain; 2010 Jul; 133(Pt 7):2007-21. PubMed ID: 20534648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sixty-hertz stimulation improves bradykinesia and amplifies subthalamic low-frequency oscillations.
    Blumenfeld Z; Koop MM; Prieto TE; Shreve LA; Velisar A; Quinn EJ; Trager MH; Brontë-Stewart H
    Mov Disord; 2017 Jan; 32(1):80-88. PubMed ID: 27859579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep Brain Recordings Using an Implanted Pulse Generator in Parkinson's Disease.
    Neumann WJ; Staub F; Horn A; Schanda J; Mueller J; Schneider GH; Brown P; Kühn AA
    Neuromodulation; 2016 Jan; 19(1):20-24. PubMed ID: 26387795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encoding of sequence boundaries in the subthalamic nucleus of patients with Parkinson's disease.
    Herrojo Ruiz M; Rusconi M; Brücke C; Haynes JD; Schönecker T; Kühn AA
    Brain; 2014 Oct; 137(Pt 10):2715-30. PubMed ID: 25031238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral double beta peaks in a PD patient with STN electrodes.
    Koeglsperger T; Mehrkens JH; Bötzel K
    Acta Neurochir (Wien); 2021 Jan; 163(1):205-209. PubMed ID: 32710183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward therapeutic electrophysiology: beta-band suppression as a biomarker in chronic local field potential recordings.
    Feldmann LK; Lofredi R; Neumann WJ; Al-Fatly B; Roediger J; Bahners BH; Nikolov P; Denison T; Saryyeva A; Krauss JK; Faust K; Florin E; Schnitzler A; Schneider GH; Kühn AA
    NPJ Parkinsons Dis; 2022 Apr; 8(1):44. PubMed ID: 35440571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct subthalamic coupling in the ON state describes motor performance in Parkinson's disease.
    Ozturk M; Abosch A; Francis D; Wu J; Jimenez-Shahed J; Ince NF
    Mov Disord; 2020 Jan; 35(1):91-100. PubMed ID: 31348550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal firing patterns in the subthalamic nucleus in patients with akinetic-rigid-type Parkinson's disease.
    Guo S; Zhuang P; Zheng Z; Zhang Y; Li J; Li Y
    J Clin Neurosci; 2012 Oct; 19(10):1404-7. PubMed ID: 22898200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic multisite brain recordings from a totally implantable bidirectional neural interface: experience in 5 patients with Parkinson's disease.
    Swann NC; de Hemptinne C; Miocinovic S; Qasim S; Ostrem JL; Galifianakis NB; Luciano MS; Wang SS; Ziman N; Taylor R; Starr PA
    J Neurosurg; 2018 Feb; 128(2):605-616. PubMed ID: 28409730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optogenetic stimulation of cortico-subthalamic projections is sufficient to ameliorate bradykinesia in 6-ohda lesioned mice.
    Sanders TH; Jaeger D
    Neurobiol Dis; 2016 Nov; 95():225-37. PubMed ID: 27452483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease.
    Foffani G; Ardolino G; Egidi M; Caputo E; Bossi B; Priori A
    Brain Res Bull; 2006 Mar; 69(2):123-30. PubMed ID: 16533660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of local field potential physiomarkers in Parkinson's disease: from clinical correlations to adaptive deep brain stimulation algorithms.
    van Wijk BCM; de Bie RMA; Beudel M
    J Neurol; 2023 Feb; 270(2):1162-1177. PubMed ID: 36209243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-motor outcomes depend on location of neurostimulation in Parkinson's disease.
    Petry-Schmelzer JN; Krause M; Dembek TA; Horn A; Evans J; Ashkan K; Rizos A; Silverdale M; Schumacher W; Sack C; Loehrer PA; Fink GR; Fonoff ET; Martinez-Martin P; Antonini A; Barbe MT; Visser-Vandewalle V; Ray-Chaudhuri K; Timmermann L; Dafsari HS;
    Brain; 2019 Nov; 142(11):3592-3604. PubMed ID: 31553039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-band frequency peaks inside the subthalamic nucleus as a biomarker for motor improvement after deep brain stimulation in Parkinson's disease.
    Michmizos KP; Frangou P; Stathis P; Sakas D; Nikita KS
    IEEE J Biomed Health Inform; 2015 Jan; 19(1):174-80. PubMed ID: 25095273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
    Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
    Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local field potential activity dynamics in response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Wiest C; Tinkhauser G; Pogosyan A; Bange M; Muthuraman M; Groppa S; Baig F; Mostofi A; Pereira EA; Tan H; Brown P; Torrecillos F
    Neurobiol Dis; 2020 Sep; 143():105019. PubMed ID: 32681881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.